| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $6,405 | 2 | 40 |
Sells | $34,851 | 3 | 60 |
| Heltzen Michael | Chief Executive Officer | 2 | $6,405 | 0 | $0 | $6,405 |
| Korman Tyler Paz | Chief Scientific Officer | 0 | $0 | 2 | $15,424 | $-15,424 |
| Perriman Damien Alan | Chief Commercial Officer | 0 | $0 | 1 | $19,427 | $-19,427 |
eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.
Over the last 12 months, insiders at eXoZymes, Inc. have bought $6,405 and sold $34,851 worth of eXoZymes, Inc. stock.
On average, over the past 5 years, insiders at eXoZymes, Inc. have bought $8,517 and sold $34,851 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Heltzen Michael (Chief Executive Officer) — $6,405.
The last purchase of 505 shares for transaction amount of $3,775 was made by Heltzen Michael (Chief Executive Officer) on 2026‑08‑26.
| 2026-10-12 | Sale | Perriman Damien Alan | Chief Commercial Officer | 3,729 0.0444% | $5.21 | $19,427 | -18.81% | |
| 2026-08-26 | Heltzen Michael | Chief Executive Officer | 505 0.0054% | $7.48 | $3,775 | -22.97% | ||
| 2026-08-25 | Heltzen Michael | Chief Executive Officer | 350 0.0038% | $7.51 | $2,630 | -22.58% | ||
| 2026-04-09 | Sale | Korman Tyler Paz | Chief Scientific Officer | 750 0.0093% | $10.53 | $7,894 | -40.39% | |
| 2026-04-08 | Sale | Korman Tyler Paz | Chief Scientific Officer | 750 0.0089% | $10.04 | $7,530 | -34.93% | |
| 2025-07-02 | Heltzen Michael | Chief Executive Officer | 1,040 0.0129% | $10.22 | $10,629 | -0.59% |
| Heltzen Michael | Chief Executive Officer | 14708 0.1585% | $69,863.00 | 3 | 0 | <0.0001% |
$2,542,362 | 111 | 11.81% | $36.83M | |
$156,891,025 | 80 | -24.91% | $36.3M | |
$84,911,583 | 59 | 17.82% | $37.44M | |
$693,326 | 47 | -16.24% | $40.24M | |
$6,204,522 | 45 | 1.91% | $36.5M |
| Increased Positions | 4 | +80% | 7,302 | +12.19% |
| Decreased Positions | 2 | -40% | 4,624 | -7.72% |
| New Positions | <1 | New | 2 | New |
| Sold Out Positions | 0 | Sold Out | 0 | Sold Out |
| Total Postitions | 7 | +40% | 62,601 | +4.47% |